scholarly journals Modeling the fate of UV filters in subsurface: Co-metabolic degradation and the role of biomass in sorption processes

2020 ◽  
Vol 168 ◽  
pp. 115192
Author(s):  
P. Rodríguez-Escales ◽  
X. Sanchez-Vila
2020 ◽  
Author(s):  
Xavier Sanchez-Vila ◽  
Paula Rodriguez-Escales

<p>The presence of ultraviolet filters (UV) in personal and care products, like cosmetics or sunscreens, is quite common. Consequently, they have been found most of water systems (e.g. ocean, river, aquifers). In porous media, the two main processes governing their fate are sorption and degradation. In the case of degradation, it is mainly governed by co-metabolism processes, which means that these molecules are broken due to the presence of more labile organic carbon which facilitate an enzymatic activity in the system. On the other hand, most of UVs are characterized by high . Thus, sorption plays a central role in their fate. In dynamic biological systems, like hyporheic zones, bioremediation sites or Managed Aquifer Recharge facilities, a high amount of microorganisms, forming biofilms, can be found. In this work, we have evaluated the role of biomass as a sorbent of UV-filters. Furthermore, we have also evaluated the importance of redox conditions in the co-metabolic degradation, and thus, the production of biomass. To achieve this general objective, a conceptual and a numerical model were developed. The results of the models were compared with previous published data by Liu et al. (2013), which performed a set of batch experiments to evaluate the fate of UV under different redox conditions. The compounds evaluated were common UV filters: Benzophenone-3, the benzotriazoles (UV-326 and UV-329)), octyl 4-methoxycinnamatte and octocrylene.</p>


2013 ◽  
Vol 22 (7) ◽  
pp. 494-496 ◽  
Author(s):  
Joan Anton Puig‐Butillé ◽  
Josep Malvehy ◽  
Miriam Potrony ◽  
Carles Trullas ◽  
Francisco Garcia‐García ◽  
...  

1995 ◽  
Vol 269 (1) ◽  
pp. E61-E66
Author(s):  
J. M. Egan ◽  
T. E. Henderson ◽  
M. Bernier

The present study was undertaken to define the role of L-arginine (L-Arg) in glucose metabolism in differentiated 3T3-L1 adipocytes in culture. L-Arg alone had no effect on 2-deoxyglucose uptake or basal glycogen synthesis, but this amino acid increased by 153 +/- 10% (P < 0.01) the incorporation of glucose into glycogen in insulin-treated cells. L-Glutamate (L-Glu), a major metabolite of L-Arg, also enhanced insulin-stimulated glycogen synthesis. The response to insulin was not altered by L-lysine (L-Lys), but the effect of L-Arg was markedly attenuated by L-Lys. Cell incubation with L-Arg markedly enhanced arginase-mediated urea synthesis, whereas L-Lys abolished this response. The stimulatory effect of L-Arg on insulin-stimulated glycogen synthesis did not appear to be accounted for by the generation of polyamines or the production of nitric oxide, both potentially derived from the enzymatic conversion of L-Arg. In the presence of insulin, cellular ATP levels were significantly increased by L-Arg, L-Glu, and L-Lys as well. These data suggest that metabolic degradation of L-Arg not related to citric acid cycle activity is important in the mechanism by which L-Arg enhances insulin-stimulated glycogen synthesis.


2002 ◽  
Vol 129 (1-2) ◽  
pp. 107-114 ◽  
Author(s):  
Soo J. Oh ◽  
Sang K. Kim ◽  
Young C. Kim

2010 ◽  
Vol 49 ◽  
pp. S209
Author(s):  
Nicholas Gad ◽  
Jasminka Mizdrak ◽  
David Pattison ◽  
Michael Davies ◽  
Roger Truscott ◽  
...  

Biomolecules ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 679
Author(s):  
Mariachiara Zuccarini ◽  
Patricia Giuliani ◽  
Francesco Caciagli ◽  
Renata Ciccarelli ◽  
Patrizia Di Iorio

Bone is one of the major tissues that undergoes continuous remodeling throughout life, thus ensuring both organic body growth during development and protection of internal organs as well as repair of trauma during adulthood. Many endogenous substances contribute to bone homeostasis, including purines. Their role has increasingly emerged in recent decades as compounds which, by interacting with specific receptors, can help determine adequate responses of bone cells to physiological or pathological stimuli. Equally, it is recognized that the activity of purines is closely dependent on their interconversion or metabolic degradation ensured by a series of enzymes present at extracellular level as predominantly bound to the cell membrane or, also, as soluble isoforms. While the effects of purines mediated by their receptor interactions have sufficiently, even though not entirely, been characterized in many tissues including bone, those promoted by the extracellular enzymes providing for purine metabolism have not been. In this review, we will try to circumstantiate the presence and the role of these enzymes in bone to define their close relationship with purine activities in maintaining bone homeostasis in normal or pathological conditions.


1998 ◽  
Vol 18 (2) ◽  
pp. 123-128 ◽  
Author(s):  
I. V. Figueiredo ◽  
M. Caramona ◽  
M. Q. Paiva ◽  
S. Guimaraes

2013 ◽  
Vol 16 (3) ◽  
pp. 97-102 ◽  
Author(s):  
Minara Shamkhalovna Shamkhalova ◽  
Ivona Renata Yarek-Martynova ◽  
Natalya Petrovna Trubitcyna ◽  
Marina Vladimirovna Shestakova

Expansion of diabetic population (predominantly due to type 2 diabetes mellitus) with chronic kidney disease (CKD) comorbidityconstitutes one of the major challenges in modern medicine.Throughout the course of diabetes nephropathy development, from its debut to the terminal stage, survival rate and quality of life arelower than those of other categories of patients. This indicates crucial role of hyperglycemia in accelerated metabolic degradation typicalof CKD.Renal disease severely narrows the spectrum of available glucose-lowering agents. Concurrent treatment for hypertension and dyslipidemia,as well as anti-platelet therapy and stimulation of erythropoiesis becomes a complex issue. A creative and patient-orientedapproach with clear metabolic and cardiovascular goals should be instrumental in its solution.


Sign in / Sign up

Export Citation Format

Share Document